DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

Agenda

Click printable agenda to view full session times, locations, and speakers. Ideal for offline use or sharing!

Día 1 23 sep 2026

11:15 AM — 12:45 PM

Session 2 Track 1: The Brains Behind Delivery of Oligos to the CNS

1:45 PM — 3:15 PM

3:45 PM — 5:15 PM

Día 2 24 sep 2026

10:00 AM — 11:30 AM

12:45 PM — 2:15 PM

Session 7 Tracks 1 and 2: Navigating the Testing Strategy for ONTs based on the Updated Q&A’s of ICH E14 and S7B

Día 3 25 sep 2026

8:15 AM — 9:30 AM

Session 9 Track 1: Targeting Muscle Diseases with Oligonucleotides

¿Tiene una cuenta?